Author: Quan-xin Long; Hai-jun Deng; Juan Chen; Jieli Hu; Bei-zhong Liu; Pu Liao; Yong Lin; Li-hua Yu; Zhan Mo; Yin-yin Xu; Fang Gong; Gui-cheng Wu; Xian-xiang Zhang; Yao-kai Chen; Zhi-jie Li; Kun Wang; Xiao-li Zhang; Wen-guang Tian; Chang-chun Niu; Qing-jun Yang; Jiang-lin Xiang; Hong-xin Du; Hua-wen Liu; Chunhui Lang; Xiao-he Luo; Shao-bo Wu; Xiao-ping Cui; Zheng Zhou; Jing Wang; Cheng-jun Xue; Xiao-feng Li; Li Wang; Xiao-jun Tang; Yong Zhang; Jing-fu Qiu; Xia-mao Liu; Jin-jing Li; De-chun Zhang; Fan Zhang; Xue-fei Cai; Deqiang Wang; Yuan Hu; Ji-hua Ren; Ni Tang; Ping Liu; Qin Li; Ai-long Huang
Title: Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice Document date: 2020_3_20
ID: dm8yl4xu_20
Snippet: Antibody detection rate based on the number of days after onset of symptoms were determined and summarized in Figure 1A There were 20 severe patients who were at the 2 nd week after symptoms onset when sampling, and 13 severe patients were at the 3 rd week when sampling. As shown in Fig. 1C , IgG and IgM titers in severe group were higher than those in the non-severe . CC-BY-NC-ND 4.0 International license It is made available under a author/fund.....
Document: Antibody detection rate based on the number of days after onset of symptoms were determined and summarized in Figure 1A There were 20 severe patients who were at the 2 nd week after symptoms onset when sampling, and 13 severe patients were at the 3 rd week when sampling. As shown in Fig. 1C , IgG and IgM titers in severe group were higher than those in the non-severe . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- cc NC ND International license and detection rate: 1, 2, 3, 4, 5, 6
- cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc NC ND International license and severe group: 1, 2, 3, 4, 5, 6
- cc NC ND International license and severe patient: 1, 2
- cc NC ND International license and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- day number and detection rate: 1, 2, 3, 4, 5
- day number and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- day number and severe group: 1, 2, 3, 4
- day number and severe patient: 1, 2, 3, 4
- day number and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- detection rate and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- detection rate and severe group: 1, 2, 3
- detection rate and severe patient: 1, 2, 3
- detection rate and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- International license and severe group: 1, 2, 3, 4, 5, 6
- International license and severe patient: 1, 2, 3
- International license and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- severe group and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date